Katharina Moller

Hamburg, HH 20246, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Journal: Biomedicines
Published: February 17, 2026

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

Journal: Diagnostics (Basel, Switzerland)
Published: February 16, 2026

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Journal: Frontiers in oncology
Published: February 12, 2026

Low E-cadherin expression is associated with poor prognosis in pulmonal adenocarcinoma.

Low E-cadherin expression is associated with poor prognosis in pulmonal adenocarcinoma.

Journal: Scientific reports
Published: December 15, 2025

Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

Journal: Gut
Published: November 21, 2025

Robot-assisted versus open pancreatoduodenectomy for cancer in the pancreatic head (DIPLOMA-2x2): study protocol for an international multicentre patient- and assessor-blinded randomized controlled non-inferiority trial.

Robot-assisted versus open pancreatoduodenectomy for cancer in the pancreatic head (DIPLOMA-2x2): study protocol for an international multicentre patient- and assessor-blinded randomized controlled non-inferiority trial.

Journal: Trials
Published: October 16, 2025

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Journal: Experimental and molecular pathology
Published: July 23, 2025

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Journal: Cancer medicine
Published: July 22, 2025

Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer.

Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer.

Journal: Lung Cancer (Auckland, N.Z.)
Published: May 08, 2025

Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors.

Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors.

Journal: Biomedicines
Published: April 23, 2025

HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.

HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.

Journal: Diagnostics (Basel, Switzerland)
Published: April 11, 2025

High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancer.

High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancer.

Journal: Translational lung cancer research
Published: April 11, 2025
Showing 1-12 of 93

Last Updated: 09/26/2026